![]() |
市场调查报告书
商品编码
1930098
全球桌上型超音波设备市场:市场规模、市场占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测(2026-2034)Table-top Ultrasound Equipment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
受急慢性疾病增加、技术进步以及全球医疗保健服务可近性提高的推动,全球桌上型超音波设备市场正经历稳定成长。根据 Fortune Business Insights 预测,2025 年全球市场规模预计将达到 69.5 亿美元,2026 年将达到 72.9 亿美元。预计到 2034 年,市场规模将进一步成长至 104.8 亿美元,2026 年至 2034 年的复合年增长率 (CAGR) 为 4.64%。亚太地区将引领市场,2025 年的市占率将达到 44.29%。这主要归因于中国、印度和东南亚国家人口老化加剧、慢性病盛行率上升以及医疗服务覆盖范围扩大。 桌上型超音波系统是指主要用于诊断和监测内臟器官、组织和血管的固定式超音波系统。心血管疾病、泌尿系统疾病和妇科疾病盛行率的上升促使患者住院人数增加,从而提高了对高品质诊断影像的需求。根据 Collective Minds 发布的 2024 年数据,全球每年将进行约 36 亿次诊断程序,凸显了超音波影像在现代医学中的重要性。
市场动态
市场驱动因素:
全球需求受到急性和慢性疾病(包括癌症、心血管疾病和妇科疾病)发病率上升的推动。人口老化进一步增加了患者住院率,并推动了对诊断检测的需求。桌上型超音波系统可提供高解析度影像,从而实现精准诊断,并帮助医疗专业人员有效监测疾病进展。西门子医疗、GE 医疗和佳能医疗等公司正在加大研发投入,推出创新产品,进一步推动市场成长。
市场限制因素:
高昂的实施成本是其广泛应用的一大障碍,尤其是在新兴市场。例如,根据富士软片Sonosite公司2025年的数据,桌上型超音波系统的价格从5万美元到超过15万美元不等,这可能会阻碍小型医院和诊所采用这些系统。
成长机会:
超音波影像在医疗领域的应用不断扩展,带来了成长机会。床边超音波系统(POCUS)能够进行更快、更准确的评估,尤其是在重症监护、急诊医学和内科领域。根据GE医疗2023年的数据,POCUS在检测腹主动脉瘤方面具有98-100%的特异性,证明了其临床有效性。
挑战:
翻新医疗器材市场可能会限制新设备的普及。翻新超音波系统在发展中国家越来越受欢迎,售价在 5,000 美元至 15,000 美元之间,为用户提供了经济实惠的替代方案。此外,低资源地区熟练超音波技师短缺和基础设施不足限制了市场扩张。
市场区隔
依类型:
依应用:
依最终使用者划分:
亚太地区将引领市场,预计到 2025 年营收将达到 30.8 亿美元。人口老化、政府医疗保健计划以及中国、印度和日本等国家先进超音波系统的日益普及是推动成长的主要因素。
北美受惠于高额的医疗支出、技术普及和有利的报销政策。策略性收购,例如GE医疗于2024年收购Intelligent Ultrasound Group PLC,正在加强其在区域市场的地位。
欧洲受益于高人均医疗保健支出和政府推广早期诊断的措施。
拉丁美洲预计将因医疗保健基础设施的扩张和人们对慢性病认识的提高而增长。
中东和非洲地区预计将因医疗设施的扩张和主要公司推出新产品而保持稳定成长。
The global table-top ultrasound equipment market is witnessing steady growth driven by the rising prevalence of acute and chronic medical conditions, technological advancements, and increasing healthcare access worldwide. According to Fortune Business Insights, the market was valued at USD 6.95 billion in 2025, is projected to reach USD 7.29 billion in 2026, and is expected to expand to USD 10.48 billion by 2034, representing a CAGR of 4.64% during 2026-2034. Asia Pacific dominated the market in 2025 with a 44.29% share, fueled by the growing geriatric population, increasing prevalence of chronic diseases, and expanding access to healthcare services in countries such as China, India, and Southeast Asia.
Table-top ultrasound equipment refers to stationary ultrasound devices primarily used for the diagnosis and monitoring of internal organs, tissues, and blood vessels. The rising prevalence of cardiovascular, urological, and gynecological conditions is increasing patient admissions, thereby driving demand for high-quality diagnostic imaging. According to 2024 data from Collective Minds, approximately 3.6 billion diagnostic procedures are performed annually worldwide, highlighting the significance of ultrasound imaging in modern healthcare.
Market Dynamics
Market Drivers:
The global demand is propelled by the growing prevalence of acute and chronic disorders, such as cancer, cardiovascular diseases, and gynecological conditions. The increasing geriatric population further escalates patient admissions, creating a higher demand for diagnostic procedures. Table-top ultrasound systems provide high-resolution imaging for accurate diagnosis, enabling medical professionals to monitor disease progression efficiently. Companies like Siemens Healthineers, GE Healthcare, and Canon Medical are investing in R&D to introduce innovative products, further supporting market growth.
Market Restraints:
High acquisition costs limit adoption, particularly in emerging markets. For example, according to 2025 data from FUJIFILM Sonosite, table-top ultrasound devices range from USD 50,000 to over USD 150,000, which may impede adoption among smaller hospitals and clinics.
Opportunities:
The increasing medical applications of ultrasound imaging present growth opportunities. Point-of-care ultrasound systems (POCUS) allow faster and more accurate assessments, particularly in critical care, emergency medicine, and internal medicine. According to 2023 GE Healthcare data, POCUS demonstrates 98-100% specificity in detecting abdominal aortic aneurysms, exemplifying its clinical effectiveness.
Challenges:
The refurbished medical device market can limit new equipment adoption. Refurbished ultrasound devices, priced between USD 5,000 and USD 15,000, are increasingly available in developing countries, providing cost-effective alternatives. Additionally, shortages of skilled sonographers and infrastructure deficits in low-resource areas constrain market expansion.
Market Segmentation
By Type:
By Application:
By End-user:
Asia Pacific dominated in 2025 with USD 3.08 billion in revenue. Growth is driven by aging populations, government healthcare initiatives, and increasing adoption of advanced ultrasound systems in countries like China, India, and Japan.
North America benefits from high healthcare spending, technological adoption, and favorable reimbursement policies. Strategic acquisitions, such as GE Healthcare's 2024 acquisition of Intelligent Ultrasound Group PLC, are strengthening regional market presence.
Europe is supported by high per capita healthcare expenditure and government initiatives promoting early diagnosis.
Latin America shows growth due to expanding healthcare infrastructure and increased awareness of chronic conditions.
Middle East & Africa is expected to witness steady growth as healthcare facilities expand and key players introduce novel devices.
Competitive Landscape
The market is consolidated with major players such as GE Healthcare, Siemens Healthineers AG, Koninklijke Philips N.V., Canon Medical Systems, Mindray, FUJIFILM, and Samsung. Companies focus on new product launches, R&D, collaborations, and acquisitions to strengthen market position. Notable developments include GE Healthcare's Versana Premier launch in 2024, Samsung's HERA Z20 OB/GYN ultrasound, and Philips' AI-enabled cardiovascular ultrasound platform.
Conclusion
The table-top ultrasound equipment market is projected to grow from USD 6.95 billion in 2025 to USD 10.48 billion by 2034, driven by rising chronic disease prevalence, technological advancements, and expanding healthcare infrastructure. Asia Pacific leads, followed by North America and Europe. Adoption of advanced imaging systems, increasing POCUS integration, and ongoing R&D initiatives are expected to enhance diagnosis efficiency, support early disease detection, and improve patient outcomes globally.
Segmentation By Type
By Application
By End-user
By Region